About Arterys Radiology
Arterys is a medical imaging AI platform that has been acquired by Tempus, now operating as Tempus Radiology. The company provides cloud-based AI solutions that extract actionable insights from medical images to add clinical value and improve diagnostic decision making, efficiency, and productivity. The platform allows healthcare providers to weave leading AI clinical applications directly into their existing PACS or EHR driven workflows, making it a natural extension of their current processes. Arterys focuses on improving physician experience, accuracy of diagnosis and treatment, financial performance, and patient outcomes. The platform is accessible anywhere from any validated device via the cloud, offering faster performance and ease of deployment with no PHI exchange while maintaining complete security. Following the acquisition by Tempus, Arterys' product is being integrated into Tempus' solutions, enabling providers to access a comprehensive patient view that includes radiology scans, and allowing researchers to leverage this new data modality to optimize the drug development process. The company serves healthcare providers and researchers in the precision medicine space.
Mission & Story
Mission
The future of precision medicine that only human + AI can achieve
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Tempus and rebranded as Tempus Radiology, with product integration into Tempus' precision medicine solutions
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.